☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Astrazeneca
AstraZeneca Reports Results from the P-III (TOPAZ-1) Study of Imfinzi for Treating Advanced Biliary Tract Cancer
April 16, 2024
AstraZeneca and Daiichi Sankyo’s Enhertu Receives the US FDA’s Accelerated Approval to Treat Metastatic HER2-Positive Solid Tumors
April 8, 2024
AstraZeneca Reports Data from the P-III Study of Imfinzi as a Treatment of Small Cell Lung Cancer
April 5, 2024
AstraZeneca and Daiichi Sankyo Report the US FDA’s Acceptance of BLA for Datopotamab Deruxtecan (Dato-DXd) to Treat Breast Cancer
April 2, 2024
AstraZeneca’s Voydeya Receives the US FDA’s Approval as an Add-on Therapy to Treat Extravascular Haemolysis in PNH Patients
April 1, 2024
AstraZeneca’s Ultomiris (ravulizumab-cwvz) Receives the US FDA’s Approval for the Treatment of Neuromyelitis Optica Spectrum Disor...
March 27, 2024
Load more...
Back to Home